Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;477(5):1339-1345.
doi: 10.1007/s11010-022-04377-5. Epub 2022 Feb 9.

Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression

Affiliations

Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression

Muhammad R Haque et al. Mol Cell Biochem. 2022 May.

Erratum in

Abstract

Opioids are the most popular drugs for both acute and chronic pain management. The G protein-coupled mu-opioid receptor (MOR) is the therapeutic target for most clinically used opioids, including morphine. A mounting number of publications suggest a relationship between the MOR and possible cancer progression and recurrence extending to managing chronic cancer pain. In this study, we studied the possible link between opioid use and pancreatic cancer (PC) progression. We found increased MOR expression in murine and human PC cell lines, human PC-derived organoids, and in the undifferentiated or poorly differentiated areas of surgically resected PC tissues. Direct stimulation of MOR by morphine (MOR agonist) caused a significant dose-dependent increase in proliferation, invasion, and levels of stemness markers in PC cells. In a co-culture system, MOR stimulation of macrophages also resulted in increased proliferation of PC cells. MOR overexpression increased proliferation and cancer stemness, whereas knock-down of MOR followed opposite results in the PC cells. Morphine induced chemoresistance to conventional chemotherapeutic agents used for PC treatment. Overall, our results suggest that MOR is expressed in pancreatic cancer and may be involved in tumor progression and chemoresistance.

Keywords: MOR; Morphine; Opioid; Pancreatic cancer.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Adamska A, Domenichini A, Falasca M (2017) Pancreatic ductal adenocarcinoma: current and evolving therapies. Int J Mol Sci. https://doi.org/10.3390/ijms18071338 - DOI - PubMed - PMC
    1. Sheikh M, Shakeri R, Poustchi H, Pourshams A, Etemadi A, Islami F, Khoshnia M, Gharavi A, Roshandel G, Khademi H, Sepanlou SG, Hashemian M, Fazel A, Zahedi M, Abedi-Ardekani B, Boffetta P, Dawsey SM, Pharoah PD, Sotoudeh M, Freedman ND, Abnet CC, Day NE, Brennan P, Kamangar F, Malekzadeh R (2020) Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study. Lancet Glob Health 8:e649–e660. https://doi.org/10.1016/S2214-109X(20)30059-0 - DOI - PubMed - PMC
    1. Kamangar F, Shakeri R, Malekzadeh R, Islami F (2014) Opium use: an emerging risk factor for cancer? Lancet Oncol 15:e69-77. https://doi.org/10.1016/S1470-2045(13)70550-3 - DOI - PubMed
    1. Moossavi S, Mohamadnejad M, Pourshams A, Poustchi H, Islami F, Sharafkhah M, Mirminachi B, Nasseri-Moghaddam S, Semnani S, Shakeri R, Etemadi A, Merat S, Khoshnia M, Dawsey SM, Pharoah PD, Brennan P, Abnet CC, Boffetta P, Kamangar F, Malekzadeh R (2018) Opium use and risk of pancreatic cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 27:268–273. https://doi.org/10.1158/1055-9965.EPI-17-0592 - DOI - PubMed
    1. Barlass U, Deshmukh A, Beck T, Bishehsari F (2021) Opioid use as a potential risk factor for pancreatic cancer in the United States: an analysis of state and national level databases. PLoS ONE 16:e0244285. https://doi.org/10.1371/journal.pone.0244285 - DOI - PubMed - PMC

LinkOut - more resources